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Lead Toxicity: Current Concerns
by Robert A. Goyer
Overthe20-yearperiodsincethe first issueofEnvironmentalHealth Perspectives was published, there has beencon-
siderable progress intheunderstanding ofthepotential toxicity ofexposuretolead. Manyoftheseadvances havebeen
reviewed inpublishedsymposia,conferences,andreview papersinEHP. Thisbriefreviewidentifiesmajoradvances as
well asa number ofcurrent concerns that present opportunities forprevention and intervention strategies. The major
scientific advancehasbeenthedemonstrationthatbloodlead(PbB)levelsof10-15pLg/dLinnewborn andveryyounginfants
result in cognitive and behavioral deficits. Further support for this observation is being obtained by prospective or
longitudinal studies presently inprogress. Themechanism(s) forthecentralnervoussystemeffectsofleadisunclearbut
involve leadinteractions withincalcium-mediated intracellularmessengersystemsandneurotransmission. Effectsoflow-
level leadexposureonbloodpressure, particularly inadultmen,mayberelatedtotheeffectofleadoncalcium-mediated
control ofvascular smooth musclecontractionandontherenin-angiotensinsystem. Reproductiveeffectsofleadhavelong
beensuspected, butlow-leveleffectshavenotbeenwellstudied. Whetherleadisacarcinogenoritsassociationwithrenal
adenocarcinoma isaconsequence ofcysticnephropathy isuncertain. Majorrisk factorsforleadtoxicity inchildren in
theUnitedStatesincludenutrition, particularly deficienciesofessentialmetals,calcium,iron,andzinc,andhousingand
socioeconomic status. A goal fortheyear2000 is to reduceprevalence ofbloodleadlevelsexceeding 15Ag/dL.
Introduction
Overthe20-yearperiodsince the firstissueofEnvironmental
Health Perspectives waspublished, therehasbeenconsiderable
progress intheunderstanding ofthepotentialtoxicityofexposure
to lead. Large numbers ofscientists and institutions have con-
tributed to these accomplishments and it is fitting that Volume
100ofEHPrecognizetheachievementsthathaveoccurred over
the lifeofthejournal. Some20 or25 years ago, thepathological
descriptions of lead toxicity consisted largely of clinically
discernibleeffectsandchangesthatcouldbe seenintissuesunder
the microscope (1). At thattime, permissible occupational ex-
posure to lead was limited to ablood lead (PbB) level of70-80
jAg/dL. PbB levels amongpeople inthegeneral population were
20-30 1g/dL, and levels in children above 40 ,Ag/dL were rec-
ognized as indicative ofleadtoxicity. Nevertheless, overthepast
2 decades there has been growing awareness and concern that
toxic biochemical and functional effects wereoccurring atlower
levels of exposure than those that produced overt clinical and
pathologicalsignsandsymptoms. These concerns were express-
ed in a tentative way in the 1972 National Academy of
Sciences/National Research Council report (2), which focused
oneffectsofairborne leadingasolineandin alaterWorldHealth
Organization Criteria Document (3). New terms such as sub-
clinical orasymptomatic leadtoxicity were appearing. TheNa-
tional Institute of Environmental Health Sciences (NIEHS)
organized one of the first conferences in 1974 to review the
emerging clinical and experimental evidence supporting low-
level leadhealtheffects, andtheproceedings ofthatconference
werepublished intheseventh issueofEHP(4). Sincethattime,
EHPhaspublishedeightothermajorconferences addressingad-
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vancesinleadormetaltoxicology (5-13)andmajorarticlescon-
cerning advances in lead research inother issues.
In 1970theU.S. SurgeonGeneralissuedastatementregarding
thecontrolofleadpoisoninginchildrenthatemphasizedtheneed
formassscreeningofchildrenatrisktoexcessleadexposureand
the need fordevelopment ofprevention strategies (14). In 1975
theCentersforDiseaseControlinAtlantarecommendedthatthe
maximumpermissiblelevelofPbBbe30 sg/dL(15). Thislevel
wasreviseddownwardin 1985to25Ztg/dL(16)andagainin 1991
(17), defining a PbB of 10 1Ag/dL as an action or intervention
level. Perhaps even more importantly, it is now suggested that
theremaybenolevelofPbBthatdoes notproduceatoxiceffect,
particularlyinthedevelopingcentralnervoussystem. Thiscon-
cernappliestothefetus inuteroandwvmenofchildbearing age.
The scientific basis for this recommendation isbriefly cited
here,butisreviewedindetailinthe 1986EnvironmentalProtec-
tionAgency(EPA)AirQualityCriteriaforLeadHealthCriteria
Document(18), followedbyasupplementin 1989(19).Thereare
alsoanumberofmorerecent,briefcommentariesonhealtheffects
ofleadinchildrenandadults(20-24). Useoftheterm"low-level
leadexposure" refers to levelsofleadnotassociated with overt
signsorsymptomsoftoxicitythatmightbeobservedclinically.
Thepurposeofthis briefreport is to summarize someofthe
achievementsthathaveoccurredduringthelifeofEHPandem-
phasize topics ofpresent research interest and identify current
concerns.
Neuropsychological Effects in Infants
and Children
SummaryofStudiestoDate
Theeffectofleadoncognitiveandbehavioraldevelopmentof
thecentral nervous system(CNS) isthecriticaleffecton infantsR. A. GOYER
andchildrenandisthefocusforcurrentpreventionandinterven-
tion strategies (17). Twenty yearsago, thegenerally recognized
effect of lead on the CNS was encephalopathy occurring in
children at PbB of80 1.g/dL orgreater. This was characterized
clinically byataxia, coma, andconvulsions andwasoftenfatal.
Survivors sufferedanumberofneurological complicationssuch
as mental retardation, deafness, blindness, andconvulsions (1).
The recognition ofprogressivelossofintellectual ability insibs
ofthoseclinicallyaffected, butwhohadlowerlevelsofleadex-
posure, contributedtotheconceptofsubclinicalorasymptomatic
CNS effects. Inthe 1974NIEHS symposium, threestudieswere
presented that were concerned with neuropsychological out-
comes in children with PbB levels below 401Ag/dL (5). In the
mid-1970s, De la Burde and Choate (25) found impairment of
finemotorfunction, conceptformation, andalteredbehavioral
profiles in70preschoolchildren withelevated PbBandhistory
ofpica compared to controls. PbB levels were greater than 30
,ug/dLinallcases; themean was59Ig/dL. Inafollow-upstudy
in 1975 onthesamechildrenat7and8yearsold, DelaBurdeand
ChoatefoundcontinuedCNSimpairmentasassessedbyavarie-
ty ofpsychological and neurological tests (26).
Inasimilartypeofstudyin 1979, Rummoandcolleagues(27)
found significant neurobehavioral deficits includinghyperactivi-
ty and lower scores on McCarthy scales ofcognitive function
among Providence, RhodeIsland, inner-city children whohad
previously experienced high lead exposure that had produced
encephalopathy. The mean maximum PbB level at the time of
encephalopathywas88 ± 40jAg/dL. However, childrenwithPbB
lower than the maximum mean did notdiffer fromcontrols on
these tests. Review ofthese data by Grant and Davis (28) sug-
gested that the failure to find significantdifferences in this lat-
tergroup wasdueto small samplesize. Theresultsoftheseand
similarstudies arealso summarizedbytheU.S. EPA(19)andin
thepublishedproceedingsofaconferenceonLeadExposureand
ChildDevelopment, withtheconclusion thatCNSeffects inin-
fantsandyoungchildrenoccurwithPbBlevelsinthe 10-15 Ag/dL
range(28). Themajormethodological problemsinthesestudies
concernconfounding factors and limitations instatisticalpower
for identifying such a small effect. Also, studies with cross-
sectional design haveproblems withestimates ofexposure.
To increase the analytical power ofstudies reported to date,
NeedlemanandGatsonis(29)performedameta-analysis on 12
previously performed cross-sectional epidemiological studies
relating children's I.Q. to PbB levels at low doses. Each ofthe
studies controlled nonleadfactorsorcovariates. Theresults sup-
ported the hypothesis that lead impairs children's I.Q. at low
doses. However, meta-analysis ofindependentstudieshavebeen
subjecttocriticism. Theymayintroducebiasinthattheyuseonly
publishedinformation, whereaspaperswithinsignificantfind-
ings tend to remain unpublished. Also, the mix ofstudies are
heterogenous intermsofdesign, methodsofleadanalysis, con-
founder structure, as well as overall statistical analysis.
To increase sample size, the World Health Organization,
Regional OfficeforEurope(WHO/Euro) incollaboration with
the Commission of the European Communities conducted a
combined study involving eight groups from eight countries
[Bulgaria, Denmark, Greece, Hungary, Italy, Rumania, West
Germany, andYugoslavia(30)]. Thestudy followed acommon
protocol with quality assurance measures to achieve com-
parability. PbBconcentration wasthemainmarkerofexposure.
The Weschler Intelligence Scale for Children (WISC) (four
subtests) forpsychometric intelligence, theBonderGestalttest
(GFTversion)andtheTrail-Makingtestforvisualmotorintegra-
tion, theViennaReactionDeviceanddelayedreactiontimetask
forreactionperformance, andtheNeedlemanscalesforbehavior
ratingsservedasbehavioralendpoints. Thecombinedindividual
studiesrepresentedasamplesizeof1879school-agechildrenand
covered a PbB range from below 5 Ag to about 60tg/dL. The
combined analysis ofthefull setofdata across studies demon-
stratedasignificantlinearrelationshipbetweenPbBandvisual-
motorintegrationandserialchoicereactionperformance. These
results were largely consistent with previous cross-sectional
studies. Psychometric intelligence as assessed by means ofthe
WISCwasalsoaffectedbyleadexposure, buttheoveralldegree
ofassociationwasofonlyborderlinesignificanceanddidnotfit
assmoothlyintotheoverallpattern offindingsasdeterminedin
the Needleman and Gatsonis meta-analysis study (29). The
authorsalsopointoutthatthefulldatasetofthislargecombined
studydidnotpermittheidentificationofaneffectthreshold, that
is, abiological exposurelimitabovewhichadversehealtheffects
are to beexpected (30).
Toovercomethedifficulties inherentincross-sectional studies
a number ofprospective studies have been instituted. Results
fromfoursuchstudiesconductedinBoston(31,32), Cincinnati
(33), PortPirie, Australia(34), andCleveland (35) arebecom-
ing available.
Bellinger and colleagues (31) are conducting a longitudinal
studyofearly neurobehavioraldevelopmentthroughthe first2
years oflife in a cohort of 170 upper and upper-middle class
Bostonchildren. Thisgrouphas shownthatperformanceonthe
Bayley Mental Development Index (MDI) at 6, 12, 18, and 24
monthspostnatallyisinverselyrelatedtoPbBleadlevelsatbirth
andthattheamountofdeficitin infantswithcord PbB levels of
10-251zg/dLisapproximately4-8pointsontheMDI. TheMDI
effectwasevidentacrosstheentire rangeofPbBlevels starting
at 10g/dL. ThemeanPbBatage24months was6.8ytg/dL(SD =
6.3; 75th, 90th, and99thpercentiles: 8.8, 13.7, 23.6,Ag/dL). After
adjusting forconfounding, scoresonthegeneralcognitiveindex
decreasedapproximately 3points(SE = 1.4)foreachnaturallog
unit increase in 24-month PbB level.
By 5 years ofage, the association between prenatal lead ex-
posure and children's cognitive function diminishedgreatly in
thecohort asawhole, except among children withhigher con-
current lead exposure risk (32). Improvement was associated
with lower PbB levels at57 months ofage. The data suggest a
socioeconomic strata(SES) effect in thatthe second year MDI
performanceoflowerSESchildren was moreadverselyaffected
at lower PbB levels (6-7 pg/dL) than was the performance of
higherSESchildren. Theseinvestigators foundimprovementin
cognitiveperformanceinchildrenfollowedfrom24to57months
ofage. Improvement wasassociatedwithlowerPbBlevels at57
months ofage. Risk ofpersistence ofcognitive deficit was in-
creased in children with higher postnatal exposure and less
favorable SES factors. Higher prenatal exposures were not
associated with lower scores at 57 months, except in the
subgroupsofchildrenwith "high" concurrentPbBlevels(i.e.,
> 10 Ag/dL).
Dietrich et al. (33) have reported interim results for neuro-
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behavioral outcomes inabout 300 infants from a study ofinner
city infants born in Cincinnati, Ohio. The children were tested
on theBayleyScales at 3, 6, 12, and24monthsofage. Afterad-
justing for covariates, deficits in 3- and 6-month Bayley MDI
scores were significantly associated withprenatal (maternal) and
cord PbB levels. The MDI deficits at 3 months were about 6
points forevery 10,ug/dLincrementincordPbBandat6months,
the MDI deficit was about 7 points per 10 ytg/dL increment in
cord PbB. However, neither prenatal nor cord PbB levels were
significantly related to the 12-month MDI scores, and by 24
months therewas no statistically significantrelationshipbetween
lead exposure and MDI scores. Deitrich et al. interpreted the
failure to detect a persistent effect offetal lead exposure on the
24 month Bayley Scales as probably due to a neurobehavioral
"catch-up response" analogous tothatobserved ininfanttwins
andothertwinscompromisedduringprenataldevelopment(33).
Inaprospective studyofmorethan500childreninPortPirie,
Australia, McMichael etal. (34) found ahighly significant in-
verse association between average prenatal PbB level and
cognitivedevelopment in4yearolds. Port Pirie islocated near
a lead smelter. Samples for measuring PbB levels wereobtain-
ed from mothers antenatally, atdelivery, frommothersand um-
bilical cordsandatagesof6, 15, and24monthsandthenannual-
ly. Concurrently, themothers were interviewed aboutpersonal,
family, medical, and environmental factors. Maternal in-
telligence, the home environment, and the children's mental
development as evaluated with use ofthe McCarthy Scales of
Children's abilities were formally assessed. Mean PbB went
from0.44ymole/L (9 ,ug/dL) inmid-pregnancy toapeakof1.03
1tmole/L (21 p.g/dL) at age 2 years. Children with an average
postnatal PbB level of 1.50ttmole/L (30 ,ug/dL) had a general
cognitive index 7.2 pointslowerthanthosewithaverage concen-
trationof0.5,umole/L(10 fig/dL). Nothresholddoseforthelead
effect was evident. However, these associations were greatly
reduced afterentering a large numberofsocial, demographic,
andbiomedical covariates intheregression model. Theauthors
suggest caution in makingcausal inferences fromthese studies
because ofthe difficulties in defining and controlling the con-
founding effects.
ErnhartandcolleaguesinCleveland(35) followedacohortof
242childreninitially identifiedatthemother'sfirstantenatalvisit
to clinics that serve the indigent population ofCleveland. By
selection, halfofthemothershadhistoriesofalcoholabuse. The
others were matched controls. By 4 years, 10 months, 260
children remained inthecohort. PbBwascollectedthroughage
3yearsandrelatedtoaseriesofdevelopmenttests. Ernhartetal.
found statistically significant correlations between mostofthe
PbB measurements and the intelligence test scores (34).
However, they found thatchanges were notconsistent in direc-
tion when relevant confounding variables wereconsidered and
concludedthatthefindingsdidnotprovideclearandconsistent
support for arelationship between pre- and postnatal PbB and
resultsofdevelopmental tests throughage3 years. Small sample
size and the fact that half of the samples were composed of
alcoholicpregnancies mayhavelimitedthisstudyandability to
detect an effect oflead, ifpresent.
Inadditiontothesestudies, reportsarenowemerging froma
numberofotherprospectivestudiesoneffectsofleadinexposure
during gestation and early childhood. These studies include
populations from Sydney, Australia; Mexico City; Yugoslavia;
Glasgow, Scotland; Christchurch, New Zealand; and Nord-
enham, Germany. Rothenbergandcolleagues(36) inMexicoCi-
ty have reported effects ofmaternal PbB at 36 weeks and birth
andofumbilical cord PbB on neurobehavioral development in
thefirst30daysoflife. They observedthat a lowerPbB level at
36weeksofpregnancyrelativetomaternalPbBlevelatbirthwas
a significantpredicator ofabnormal reflex as measured by the
Brazelton Neurobehavioral Assessment Scale. Mean PbB of
motherswas 15.0ytg/dLat36weeksand 15.0Ag/dLatbirth. The
PbB level ofinfants at birth was 13.8 ig/dL.
Takentogether, theabove studiesdemonstratethatleadhasan
adversehealtheffectonneurobehavioral andcognitivedevelop-
mentatPbBlevels inthe 10-15Ag/dLrange in infants, children,
andthe fetus, andperhaps at even lowerlevels. Themagnitude
ofI.Q. decrements are dose related, as shown in Figure 1.
Theimportanceofa4-7pointreductioninI.Q. mayatfirstap-
pearunimportant, butfurtheranalysessuggestthatsmallchanges
areofconsiderablesignificance. Whentheactualcumulativefre-
quencydistributionofI.Q. betweenhigh-andlow-leadsubjects
areplottedandcompared, thereisanearly4-fold increase inthe
numberofchildrenwithaseveredeficit, thatis, I.Q. scoresbelow
80. Thereisalso a5% reduction inthenumberofchildrenwith
superior function (I.Q. > 125). There is currently no estimate
ofthe costofthis effect to society in social or monetary terms.
Reversibility ofCNS Effects
There is now question as to whether the small changes in
behavioralandcognitivedevelopmentobservedinrecentstudies
isreversible. Thetwoprospective studies fromBoston (37) and
Cincinnati (33) ofcognitiveeffectsofneonatal exposureto lead
suggestsomereversalmayoccurifPbBlevelsdeclineduringear-
ly childhoodand SES is favorable. However, Needleman et al.
(38) found adecreaseinneurobehavioral functionpersistent into
adolescence in a group with higher PbB levels (> 30/Ag/dL).
They followed 132 young adults initially studied as primary
schoolchildren in 1979. At that time neurobehavioral function
was inversely related to dentine lead levels; the children were
dividedintotwogroupsbasedondentineleadlevels. Thehigh-
levelgrouphadanaveragePbBlevelof35.5 yg/dL;thelow-level
grouphad anaveragePbBlevelof23.8ltg/dL. Needlemanetal.
found that lead content of teeth shed at ages 6 and 7 was
associated withanincreaseindropoutratefromhighschool and
readingdisability (38). Higherleadlevels werealsoassociated
withlowerclassstanding, increasedabsenteeism, lowervocabu-
laryandgrammaticalreasoning scores, poorerhand-eyecoor-
dination, longer reaction time, and slower finger tapping.
Needlemanetal. concluded that PbB levels inchildhood >30
jig/dLareassociatedwithdeficitsincentral nervoussystemfunc-
tion thatpersist into young adulthood (38).
Mechanisms ofCNS Effects
Twentyyearsormoreago, knowledgeofmechanismsoflead
toxicity waslargely based on autopsy findings ofchildren who
diedwithleadencephalopathy. Themajorfindingswereasevere
edemaofthebrainrelatedtoanincrease inproteinaceous tran-
sudatefrompermeablecapillariesandintercapillary spaces (1).
AnexampleofthisphenomenonisshowninFigure2. Although
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FIGURE 1. General pattern ofresults from cross-sectional population studies ofexposureeffects oncognitive function as reflectedbydeficits inI.Q. scores on various
standardized tests. The magnitude ofI.Q. decrements associated with a broad range ofblood lead (PbB) levels is estimated here based on evaluation ofstudies
noted andcommented on in text. More recentprospective studies identify leadeffects onI.Q. from PbB levels as low as 10-15,g/dL orperhaps lower. R, Rum-
mo studies (27); D, de la Burde studies (25,26); N, Needleman studies (29); W, Winneke studies (30); UK, studiesby Smithetal. (39). This figure is adapted
with permission from Grant and Davis (28).
FIGURE 2. Photomicrograph ofsection ofcerebral cortex taken at autopsy ofachilddyingofacuteleadencephalopathy showingblood vessel (BV) surrounded by
lead-containing edema fluid. Pathological effectsoflead are a consequenceoftoxicity to neuronsandneurotransmitters andaccompanying increase in intracere-
bral pressure edema. E, edema (transudate). Photomicrograph is provided through the courtesy ofDavid Munoz (Neuropathology, University Hospital, Lon-
don, Ontario).
the mechanisms by which lead disrupts brain function and the
reasons fortheapparentincrease in sensitivity ofthe immature
brain to lead toxicity are not yet completely understood, our
knowledge has increasedconsiderably. This new informationis
contained in many publications including articles from an
NIEHS conference onAdvances in Lead Researchpublished in
EHP(12).
Itissuggestedthattheimmatureendothelial cells formingthe
capillaries ofthedevelopingbrain arelessresistanttotheeffects
oflead thancapillaries from maturebrains. Thesecells permit
fluid and cations including lead to reach newly formed com-
ponentsofthebrain, particularly astrocytes and neurones (40).
Markovac andGoldstein (41) investigatedtheeffectsofinorganic
lead oncalcium, phospholipid-dependent proteinkinase(protein
kinase C) inbrain microvessels from6-day-old rat pups. They
found that micromolar concentrations oflead activate this en-
zymeto anextentequivalenttomicromolarcalcium, suggesting
this may be a sensitive mechanism for lead cellular toxicity in
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capillaries by resulting in a breakdown in the normally tight
blood-brain barrier.
Exposureofthedeveloping fetus toleadmay result inhigher
brain accumulation thanpostnatal exposure. Rossouwetal. (42)
compared brain lead levels following a 3-week postnatal ex-
posure, either preweaning (days 1-21) or post-weaning (days
22-43) and exposure ofthe fetus via maternal administration.
Theexposureinuteroresulted ina6-fold increaseintotalbrain
lead (1.07 pg/g) versus 3.5-and2-foldincreasesattheothertime
points (0.84 ytg/g and 0.44Aglg). Exposures at these three dif-
ferentdevelopmental phasesalso resulted indifferential effects
on monamine and cholinergic receptors. Significant differences
were found ineithersuckling orfetal rats with nochangesafter
post-weaning exposure.
Neurochemical studies in experimental models have shown
that lead, in the absence of morphologic changes, produces
deficits in neurotransmission through inhibitionofcholinergic
function, possibly by reduction ofextracellularcalcium. Other
notedchanges inneurotransmitter functionincludeimpairment
of dopamine uptake by synaptosomes and impairment of the
function ofthe inhibitory neurotransmitter a-aminobutyric acid
(18).
There is also some experimental evidence to suggest thatthe
fetal brain may have greater sensitivity to lead than the mature
brain. Ratpupsreadilydevelopencephalopathyduringthefirst
few daysoflife, and resistance tolead-inducedneurotoxicity oc-
curs after 18-20 days ofage. The development ofresistance to
lead encephalopathy is thought by Holtzman and co-workers
(43) to be related tothe formationoflead-proteincomplexes (in-
clusion bodies) in astrocytes that sequester lead away from
mitochondria. This roleoflead-proteincomplexingissimilarto
that postulated in renal tubularepithelial cells as a mechanism
forpermitting thekidneytoexcreteleadwithoutcellulartoxicity
(43). The lead protein complexes are thought to contain a
number ofrichly acidic proteins (44,35). More recently, Egle
and Shelton(46)have identifiedthemostabundantproteincom-
ponentofisolated inclusionbodies tobeaconstitutiveproteinof
the central nervous system, most abundant in the cerebral cor-
tex. In rat brain, the protein was found to be developmentally
regulated. Only tracesweredetected3daysafterbirth, butwithin
1-2 weeks adult levels were achieved. These studies suggest,
therefore, that this cellular mechanism to sequester lead is not
present in the fetal brain.
Cardiovascular Disease
Effectsoflead oncardiovascular disease havebeen suspected
formany years. However, theevidence 20yearsago was large-
ly negative apart from a few conflicting research reports (1).
Epidemiological studiesoflead effectonbloodpressure in oc-
cupationallyexposed workersshowedessentially noeffect. The
reasoning followedthat ifheavilyexposedworkerswerenotaf-
fected, itwasnotlikely thatlesserexposedpeopleinthegeneral
population wouldbe adversely affected. Nevertheless, analysis
oftheSecondNatonal HealthandNutritionExaminationSurvey
data (47) showed a significant linear associationbetween PbB
concentrations and blood pressure. Additional analysis ofthe
databy Pirkle etal. (48) focusedonwhitemalesaged40-59. In
the range of7-34 4g/dL, there was noevident threshold below
which PbBlevel was notsignificantlyrelatedtobloodpressure.
The dose-response relationship indicated that large initial in-
crements inblood pressure occur at relatively low PbB levels,
followedby levelingoffofbloodpressureathigher PbB levels.
Thismayexplainwhyabloodpressureeffectwasnotprevious-
ly identified in a lead-exposed worker population. However, a
leadeffectonbloodpressureonworkerswithlowlevelexposure
hasbeenmorerecentlydemonstrated. Sharpetal. (49) reported
arelationshipbetweenleadexposureandelevatedbloodpressure
inSanFranciscobusdriversexaminedusingmultipleregression
analysis. Systolic anddiastolicpressures varied from 102 to 173
mmHg and from 61 to 105 mmHg, respectively. The PbB con-
centration varied from 2 to 15 Ag/dL. Effect on blood pressure
is now identified as the critical effectoflead in adults (19).
The mechanism whereby lead affects blood pressure is not
known, although experimental studies have suggested several
plausible possibilities. Much of this is contained in an EHP
publicationofProceedingsofa 1988SymposiumonLead-Blood
Pressure Relationships (11) and a recent review by Schwartz
(50). Two major mechanisms ofaction are an effect oflead on
the calcium-mediated control ofvascular smooth muscle con-
traction and renal effects mediated through renin-angiotensin
system. Theworkofseveral investigators presented atthe 1988
symposium suggestthatlead increases pressor responsiveness
tocatecholamines, whichmaybe aconsequenceofthe lead ef-
fectonthe intercellularmessengerproteinkinaseCand its role
insmoothmusclecontraction (51). Thehumanandexperimental
data on leadeffect on therenin-angiotensin system is not clear
withfindingsofboth increasedanddecreasedplasma reninac-
tivity followingexposure. Vander(52) suggests fromexperimen-
tal studies on rats and dogs that there is an initial increase in
plasma reninactivity followedby gradual reductionwithchronic
exposure.
Bone
Metabolic Effects
Leadinboneisofinterest fortworeasons. Boneisthelargest
repository ofthe body burden oflead, and, secondly, it is now
recognized that lead may, in fact, have an effect on bone
metabolism. Of current concern is that lead in bone may be
mobilized during a number ofphysiological and pathological
conditions such as age, endocrine status, osteoporosis, renal
disease and, in particular, during pregnancy and lactation.
Silbergeld (53) has summarized a number ofimportant factors
indeterminingtheextenttowhichbonelead maybemobilized
duringgestation. Obviously, themostimportantofthesefactors
isthelevelofleadinbone. Rabinowitz(54)hassuggestedthatthe
dose rateofleadexposureinfluences locationandconcentration
of lead in different sites in bone, which may influence its
availability for mobilization. Other factors are maternal age,
gestational age,parity, andrace. Themajordeterminantforeach
ofthese factors is nutritional status, particularly dietary calcium.
Poundsandco-workers(55)havereviewedthepossiblemech-
anisms whereby lead may directly or indirectly alter several
aspectsofbonecellfunction. Clinicalstudieshaveshownthatex-
posure to leadmay changecirculating levelsof1,25-dihydroxy-
vitaminD3. Secondly, leadmayaffecttheabilityofbonecellsto
respond to hormone regulation. A calcium-binding protein,
osteocalcin, synthesizedbyosteoblasts, is inhibitedatlow levels
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ofleadexposure, whichmay impairnewboneformationaswell
as the functional coupling ofosteoblasts and osteoclasts. Lead
may also impairsynthesisofcomponentsofbonematrix suchas
collagen orbone sialoproteins. Acommon molecularbasis for
thecellulareffectsmaybealteredorimpairedcalciumandcAMP
messenger systems in cells.
Measurement ofLead in Bone
There is increasing interest in the developmentofanalytical
systems basedontheprincipleofX-rayfluorescence (XRF) for
the in vivo measurement oflead in bone. Three basic designs
havebeen reported intheliteratureandsummarizedbyThomas
(56). Two ofthese use excitation anddetection ofK X-rays of
lead; thethirdusesexcitationanddetectionofLX-rays. Thema-
jordifference intheKand Lsystems isthephotonsourcethatis
used, either '09Cdor57Co. Bothtypesofsystemsusingdetection
of K and L X-rays involve relatively low energy incident and
emitted photons and aretherefore limited to measuring lead in
superficial bone. L X-ray systems have been applied only to
measuring thecorticalregionofthetibiawhereoverlyingtissue
isthin inordertohavemaximum penetration. Depthofmeasure-
ment isapproximately 2.8 mm. Sensitivity decreases to 30% at
approximately 1.3 mm. Sensitivity ofsystems using K X-rays,
however, have a 30% reduction in sensitivity at sites approx-
imately 25 mmfromthesurface. Thissystem, therefore, hasthe
potential foruseatanumberofbonesites, buthasbeenusedfor
primarily measuring lead in sections of the phalanx or tibia.
Whether resultsofthesemeasurementscanbeusedtoassesstotal
body burdenoflead is currently uncertain. Themajor limiting
factoris thelimitofsensitivity forlead inthecommon rangeof
10-20 ppm. Rosen et al. (57) have performed sequential
measurements ofbone lead in CaNa2 EDTA-treated lead-toxic
children usingLX-ray fluorescence. Inthis systemtheminimum
detection limit was 7 pg oflead/g ofbone. Cortical bone lead
values were similar to lead concentrations measured via bone
biopsy in normal adults and lead workers and were apredictor
of CaNA2 EDTA treatment outcomes in 86% of lead toxic
children (PbBof25-55 ,ug/dL) comparedtoa93% resultusing
PbBasapredictor. Aquestioniswhetherthespecificity andsen-
sitivity ofthissystemcanbeextendedtomeasureboneleadlevels
present in children with minimal or low-level lead exposure.
Reproductive Effects
It has been recognized for decades that severe lead intoxica-
tion isassociated with sterility, abortion, stillbirths, andneonatal
morbidity and mortality from exposure in utero (1), but the
potential foreffects oflow-level leadexposure onreproductive
fitness inmales andfemales isonlybeginning to receivetheat-
tentionofexperimental andclinicaltoxicologists. Inarecentcon-
ferenceonAdvances inLeadResearchreported inEHPin 1990,
several presentations focused oneffectsonthefetusinutero, but
little new information vws available regarding effects on re-
production (12). Nevertheless, thereareindications ofdevelop-
ing interest.
InarecentstudyperformedinYugoslavia, semenqualityfrom
152 male volunteers with no occupational exposure to lead or
cadmium wascompared to 101 workerswithslighttoexcessive
occupational exposure to lead (58). Median PbB of control
workers was 10.7 pg/dL (range 6.7-20.8 Ag/dL) and exposed
workers 37.1 pgldL (range 11.7-104.0 ,ug/dL). Increase in PbB
reduces semen volume, semen density, counts oftotal, motile,
and viable sperm, percentage ofprogressively motile sperm,
levelsofzinc, acidphosphatase, andcitricacid, andincreasesthe
percentage ofpathological sperm. Thesedata suggestthatmale
reproductive effects may also occur at PbB levels at the 30-40
pg/dL range or even lower.
Therearenorecentstudiesoneffectsofleadonreproductive
functionin women, although ithasbeenknown formany years
that lead may be an abortifacient when women are acutely
exposedtohighdoses. Arecentstudyconductedby Healthand
Welfare, Canada (59) on female nulliparous monkeys has in-
dicatedthatchronic exposuretoleadwithPbB levelsofapprox-
imately 35 Lg/dL resultedin subclinical suppressionofcirculat-
ing luteinizing and follicle-stimulating hormone and estradiol
without overteffects on general health and menstruation.
Nephrotoxicity and Carcinogenesis
LeadNephropathy
Lead nephropathy in rodents progresses to renal adenocar-
cinoma. However, a similar relationship betweennephropathy
inworkerswithoccupational exposuretoleadandrenalcancer
has notbeenclearly established fromepidemiological studies,
although two case reports have been published (60,61). The
potential carcinogenesis oflead has been reviewed recently by
EPAbecauseoftheuncertaintyofthisrelationship(62). Leadef-
fects on the kidney have provided one ofthe oldest and most-
studiedexperimental modelsofcellulareffectsoflead. Clinically
important renaleffects ofleadareuncommon today andeffects
oflow-level exposureonrenal functionandevencarcinogenesis
isnotknown. Thecommentsinthisarticlearelargelytakenwith
permission fromapresentation IgaveataSocietyofToxicology
symposium in 1991, which was recently published (63).
Overt effects oflead on the kidney in man and experimental
animals, particularly theratandmouse, begin with acute mor-
phologicchangesconsistingofnuclearinclusionbodiesorlead-
proteincomplexesandultrastructuralchanges inorganelles, par-
ticularly mitochondria. Progression of acute nephropathy to
chronic irreversible nephropathy occurs slowly, overmonths or
years, and only afteryears ofheavy exposure.
Selevanetal. (64) reviewedthepatternsofdeathforacohort
of1987malesmelterworkersemployedbetween 1940and 1965.
Althoughoverallmortality was similartothatoftheU.S. white
male population, there was an excess mortality from chronic
renaldisease. Theriskofdeathfromrenaldiseaseincreasedwith
increasingdurationofemployment. Inamortalitystudyof4519
battery plant workers and 2300 lead production workers by
Cooper and co-workers (65), there was excess mortality from
chronic nephritis. The mean PbB concentration of 1326 ofthe
batteryworkersinthisstudywiththreeormoreanalyseswas62.7
Ig/100 g, 404 had means of 70 pg or more, 24 of which had
meansover 100,ug/100g. Fortheleadproductionworkers infour
plants, the meanfor537 men was79.7pg/100g. These workers
werethereforeexposedtoleadinamountsfarexceedingpresent
workplace standards.
Experimental studiessuggestthattheremaybeathresholdfor
lead nephrotoxicity. Ratsexposed todifferentdoses oflead for
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upto 12 weeks suggestthatPbBlevelof60Ztg/dListhethreshold
forproximal tubularcell injury fromlead(66). ThislevelofPbB
isequivalent tokidney leadofabout45g/gandistheleveloflead
atwhich renalcalcium increases andultrastructural changes in
proximal tubular cell mitochondria occur. This finding is con-
sistent with the observation ofBuchet et al. (67) that workers
whodonothaveaPbBlevelover62or63,g/dLforupto 12years
do not have lead nephropathy.
Renal biopsies ofasmall groupofshipwreckers withheavyex-
posure to lead has shown that histologic features ofearly and
chronicexposuretoleadis similar inexperimental animalsand
man, suggesting similarpathogenetic mechanisms(68). Nuclear
inclusionbodies becomelesscommonasrenaltubularatrophy
and interstitial fibrosis increase in severity. Proximal tubular
dysfunction isusually notdemonstrable inthechronicphaseof
lead nephropathy, but interstitial fibrosis is usually associated
withasymptomatic renalazotemiaandreducedglomerularfiltra-
tion rate. In workers without azotemia but decreased insulin
clearance, thereisdecreasedmaximumreabsorptionofglucose.
Althoughprogression fromacute, reversible tochronic, irrever-
sible lead nephropathy has not been clearly shown to occur in
man, thisprogression hasbeen demonstrated in rodentmodels.
Lead andCancer
Thereareseveral experimental studies inratsormiceinwhich
long-term administrationofa lead compound in food ordrink-
ing water produced renal tumors. The studies have been sum-
marizedbytheEPA(62)andinearlierreviews(69). Thestudies
show that renalcarcinogenicity occursonabackgroundofprox-
imal tubular cell hyperplasia, cytomegaly andcellulardysplasia.
Renal adenocarcinoma occurs in ahigh percentage ofexposed
animals, andincidence isdependentonlengthandseverity ofex-
posure (70,71).
Males are more susceptible to tumors than females. Tumors
have notbeenshown tooccurbelowthemaximumtolerateddose
(72,73) of200 ppm oflead in drinking water. This is the max-
imum dose oflead in rats notassociated with any morphologic
orfunctionalevidenceofrenaltoxicity inratsfedadietcontain-
ing adequate levels ofessential minerals, particularly calcium
(74).
Epidemiologic studies of workmen exposed to lead in a
number of different occupational settings have been reported
(62). Mostofthe studies areproportional mortality studiesand
contain numerousdeficiencies, particularly lackofinformation
oncumulative leadexposure. Anonsignificant excessofkidney
cancer wasobservedinacohortmortalitystudyofprimarylead
smelterworkers (64), butthis wasbasedononly sixcases. Can-
tor et al. (75) found a borderline significant excess ofkidney
cancer in a study of 7121 members and retirees ofthe United
AssociationofPlumbersandPipe Fitters inCalifornia. Inaddi-
tion, there havebeen two case reports ofkidney cancer among
lead workers (60,61). Excess lung cancers were observed in
several studies, butthesecannotbeattributed toleadbecauseof
confoundingexposures tootherheavymetals, includingarsenic
andchromiumandtosmokingcigarettes. Also, ineachstudythe
presence ofother potentially carcinogenic agents in the work-
placemakeitdifficulttodetermineifany increaseinriskisdue
toleadper seorpossiblyotheragents. Nevertheless, thestudies
overall do not provide conclusive evidence of an association
ofleadexposure andan increased incidence ofcancer (62,76).
Mechanisms for Lead Carcinogenesis
Table 1 is a short list ofpossible mechanisms whereby lead
may inducerenaltumors. Thefollowingbriefcommentsarepro-
vided regarding eachoftheproposed mechanisms. The mech-
anisms are not mutually exclusive, nor is supportive evidence
complete inany case.
Leadisthoughttohavegenotoxicproperties, butlead-induced
gene mutations in cultured mammalian cells have only been
observed attoxic concentrations. Studies forpointmutations in
bacterial systemshavebeennegative, butthesesystemsareusual-
ly negative and may be inappropriate for assaying metal ions.
However, Zelikoffand co-workers (77) foundthatboth insolu-
ble lead sulfide and more soluble lead nitrate were mutagenic
whenaddedtoChinesehamsterV79cells. Theyalsofoundthat
lead acetate induces morphological transformation in Syrian
hamstercells. However, they concludethattheseeffectsmay not
betheresultofdirectdamagetoDNA,butmayoccurviaindirect
mechanismsincludingdisturbancesinenzymefunctions impor-
tantinDNAsynthesisand/orrepairorinDNAhelical structure.
Theseeffectsmayalsobeinfluencedby synergisticfactors such
as calciumdeficiency.
The occurrence ofnuclear inclusion bodies or lead-protein
complexesinproximaltubularcellsoflead-exposedanimalsand
humans hasprompted speculationthatthe nonhistoneproteins
involved intheformationofthesebodiesaltersgenetic function
insomeway,butthereisnodefinitivebasisforthisassumption.
Theobservationthatpicomolarconcentrations ofleadacetate
can activate partially purified protein kinase C from rat brain
suggeststhatleadmaybeacting asaco-carcinogenortumorpro-
moter (41). This enzyme is regulated by availability of both
calcium anddiacylglycerol, is activatedby a numberofknown
tumorpromoters, andisthoughttobetheprimarycellulartarget
forthe phorbol esters. The activated enzymephosphorylates a
number ofcellular protein substrates including growth factor
receptors and oncogenes.
Thereisalsoin vivoevidencethatleadmayactasatumorpro-
moter. Leadincreaseslungtumorincidenceandlungtumorsper
mouse in a mouse lung adenoma model (78) and increases
cerebralgliomasinrats(79). Additionofleadacetatetothediets
ofrats exposed to N-(4-fluorobiphenyl)4-acetamide, a known
carcinogen, increasesrenaltumorto 100% suggestingthatlead
may be a promoter (80).
Leadisamitogen. ExposuretoasingleIPinjectionstimulates
a 40-fold increase in cell proliferation in rats as measured by
autoradiography and is furtherincreasedbyunilateral nephrec-
tomy (81). DNA synthesis in kidneys as measured by 3H-thy-
midine incorporation is increased 15-fold and mitotic index
45-fold following asingleintracardiac injection oflead acetate
Table 1. Possiblemechanisms relating renal carcinogenesis
tolead-induced chronic nephrotoxicity.
Mutagenicity
Nuclearproteineffect (inclusion bodies)
Promoter activity, activation ofprotein kinase C
Cellularproliferation
Cystichyperplasia
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in mice (82). More recently, cell proliferation andhyperplasia
were seen inthe liverofrats given a single IV injection oflead
nitrate (83). Inboth ofthesemodels, increases incellprolifera-
tionoccurred intheabsenceofcellularnecrosis, suggesting this
is a mitogenic response rather than a regenerative response.
Cystichyperplasiaisalatemorphologic featureofchroniclead
nephropathy inhumans andexperimental animalsandimposes
an increased risk of malignancy (84). Cystic hyperplasia has
been foundtobeamorphologicprecursortoadenomaformation
in animals treated with renal carcinogens, nitrolotriacetic acid
(85), in ratsexposed toN-(4-fluoro-4-biphenyl)acetamide (86),
and in persons with hereditary adultpolycystic kidney disease
(87)andacquired renalcysticdiseaseoccurring inpatientswith
chronic renal failureonhemodialysis (88). Oneoftheproposed
hypotheses relating disorderedepithelialcellgrowthtorenalcyst
formation suggeststhatcellsliningcystsbecometransformedand
proliferateabnormally, presumably inresponsetoincreased in-
tracystic fluid volumes. Regardless of the mechanism, the
available literature fromboth humanand experimental studies
suggestthatrenal cystformationasoccursinchronicrenal failure
inducedbyleadorfromavarietyofothercauses, geneticorac-
quired, contributes to anincrease in renal adenocarcinomas. In
such cases, the adenocarcinoma is a consequence ofthe cystic
change intherenal cortexthatfollowschronic leadnephropathy.
Major Risk Factorsfor Lead Toxicity
In the second issue ofEHPabout 20years ago, an article on
susceptibility to leadtoxicity reviewed anumberoffactorsthat
influence risktoleadtoxicity (89). Manyoftheissuesdiscussed
then are relevant today, but research over the past20years has
shown some to be ofgreater significance than others. Table 2
identifies whatarecurrently themajorriskfactors. Itis impor-
tantto identify such factors forthemanagementoftheleadtox-
icity problembecausecontrol ofthefactorsprovidethegreatest
opportunity for targeting primary prevention and intervention
strategies.
Age
Infants andyoung children havelongbeen known tobe atin-
creased risk to toxicity to lead because of higher lead intake
relative to body size and greater absorption from the gastro-
intestinal tract. The central nervous system ofthe developing
fetus may be at even greater risk because ofimmaturity ofthe
blood-brainbarrier.
The ratio ofPbB to tissue organ lead also changes with age.
Therapidgrowth rateduringthe firstfew monthsofliferesults
in declining lead dose in terms of absolute intake per body
weight. The fraction oflead in bone also increases with age.
Barry has shown that 73% of body lead is in bone during
childhood, increasing to approximately 95% in adult life
(89,90).
Table 2. Majorrisk factors for lead toxicity.
Age
Nutrition (food intake)
Essential metals
Calcium, iron, zinc
Housing and socioeconomic status
Nutrition
Mahaffey has summarized the influence oftotal food intake
andpatternsoffood intakeonleadtoxicity (91). Severalobser-
vations have been made. Lead intake from water and other
beverages isabsorbedtoagreaterdegreethanleadinfood. Lead
ingestedbetweenmeals ismoregreatlyabsorbedthanleadwith
meals, and increasing frequency offood intake minimizes lead
absorption. Thecomposition ofthediet, particularly high pro-
teincontent, wasshowninexperimental studiesmanyyearsago
todecreaseleadintake, buttherehasbeenlessinterestornew in-
formation regardingthis factorinrecentyears. Lead interactsor
competes forgastrointestinalabsorption, tissuedeposition, and
as a co-factor in metallo-enzymes with essential trace metals,
particularly calcium, iron, andzinc. Deficiencies ofcalcium and
ironclearlyenhanceleadabsorption. Ithasbeenrecognized for
many yearsthatleadmetabolismmimicscalciummetabolism in
manyways. Itisalsoclearfromanimalstudiesthatcalciumdefi-
ciency greatlyenhances leadabsorptionandthatperiods oflow
calcium mobilizelead fromtissue stores, particularlybone. This
isparticularlytrueforfetalgrowthinuterowhereincreaseinfetal
tissue lead parallels increase in tissue calcium (92). This
phenomenon also occurs during lactation where lead appears
alongwithcalciuminmothers' milk(93). Atopicofspeculation
with little evidence to date is to what degree calcium excess
beyond recognized daily requirements diminishes lead uptake
andtissuetoxicity.
Leadcompetes with zinc as aco-factor with heme enzymes,
particularly aminolevulinicaciddehydrataseandferrochelatase.
Iron deficiency increaseserythrocyteprotoporphyrin activity as
doincreasingPbBlevels, probably notbecauseofco-factorcom-
petitionbutbecausebothmetals stimulate precursorsynthesis.
Oneofthemostprovocativeobservations, reportedbyOski etal.
(94), is that irontherapy improvesdevelopmental scores ofin-
fants. The molecular basis for this is unknown and remains an
area needing further clarification. Increasing zinc in the diet
reducestissueaccumulationandtoxicityoflead(95). Thiseffect
is thought tobe due to enhanced gastrointestinal absorption of
lead because zinc deficiency does not enhance toxicity of
parenteral lead.
Housing and Socioeconomic Status
Ithasbeenrecognizedforseveraldecadesthatchildrenliving
in older housing containing paint with high lead content are at
high risk for excess lead exposure and toxicity. An in-depth
analysis ofthis problem is contained in a 1988 report from the
Agency for Toxic Substances and Disease Registry (96). This
analysis concludes that about 2.4 million white and black
metropolitanchildren, orabout 17% ofsuchchildrenintheU.S.
metropolitanareas, areexposedtoenvironmental sourcesoflead
at concentrations that place them at risk to lead toxicity. The
numberapproaches3millionblackandwhitechildrenifextend-
edtotheentireU.S. population, andmaybeasmanyas4million
children ifchildren fromotherracial groups (Hispanic, Orien-
tal, andotherorigins) areincluded. Ofthesechildren, about5%
havePbBlevelsgreaterthan204tg/dL. Black, inner-city, orlow-
income stratahaveamuchhigherpercentagewithelevated PbB
levels, although noeconomic orracialsubgroup isexempt. Fur-
thermore, anestimated 400,000 fetuses in utero are exposed to
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maternal PbBlevels greaterthan 10ug/dLandarethereforealso
at risk to lead effects.
Othermajorenvironmental sourcesoflead inaddition topaint
arelead indust, soil, food, andwater(18). Leadlevelsindustand
soil result from past and present inputs from paint, air fallout
frompaintemissions, andleadingasoline. Whileleadinpaint,
dust, and soil arethemajorenvironmental sourcesofexposure,
lead indrinking waterprovides a significant risk, particularly as
anadditive factor. Furthermore, theolderthehousing, themore
likely theremaybeleadpiping. Reductionofleadingasolinehas
reduced atmospheric lead fallout deposited in water, dust, and
soil and has probably contributed to reduction oflead in food.
Eliminationoftheuseofleadsolderincannedfoodhasalsocon-
tributed to reduced lead in food. Continued progress in these
areas will play a major role indiminishing oreveneliminating
the risks to lead toxicity.
The Future
Inastatementtitled "Promoting Health/Preventing Disease:
Year2000, Objectives fortheNation," thePublicHealthService
goal isto "reducetheprevalence ofblood leadlevels exceeding
15 1g/dL and25 14g/dL among children ages 6 months through
5 years to no more than 500,000 and zero" (97). A special
population targetis innercity blackchildren (annual family in-
comeoflessthan$6000in 1984)ages6monthsthrough5years.
Toachievethisgoal, the DepartmentofHealthandHumanSer-
vices and the DepartmentofHousing and Urban Development
and the Environmental Protection Agency have released a
strategic plan for the reduction ofleadpoisoning. Major com-
ponentsoftheplanarepreventionactivities, increasedabatement
ofenvironmental exposures, principally housing with leadcon-
taining paint, and national surveillance programs essential to
identifying progress andchildren at risk.
Alsoessential totheplan is increasing researchtounderstand
the health hazards caused by exposure to lead. Many of the
studies, particularly thebasic researchcontainedinthis report,
have been supported by theextramural programofthe NIEHS.
Currently more than $8 million per annum is directed to lead
research from NIESH. Itis hoped that we can address many of
the current concerns outlined here inthe future.
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